This is the classic website, which will be retired eventually. Please visit the modernized ClinicalTrials.gov instead.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cancer Prevention for Young Rural Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05618158
Recruitment Status : Not yet recruiting
First Posted : November 16, 2022
Last Update Posted : July 11, 2023
Sponsor:
Collaborators:
National Cancer Institute (NCI)
University of Arizona
University of Utah
Colorado State University
University of Colorado, Denver
University of New Mexico
Information provided by (Responsible Party):
Klein Buendel, Inc.

Brief Summary:
Young adults aged 18-26 engage in a number of behaviors that increase their risk of developing cancer later in life including sedentary lifestyles, unhealthy eating, nicotine produce us, heavy drinking of alcohol, increased UV exposure, and incomplete uptake of HPV vaccination. A multi-risk factor campaign will be developed to reduce these cancer risk behaviors and delivered to young adults over social media, a popular channel that can reach nearly all young adults. The campaign will be evaluated for effectiveness in a rigorous randomized trial with measures of moderate to vigorous physical activity, healthy eating patterns, nicotine product use, alcohol intake, sunburn prevalence, and HPV vaccination uptake.

Condition or disease Intervention/treatment Phase
Cancer Behavioral: 4 Corners Rural Health Cancer Prevention Not Applicable

Detailed Description:
Several risk factors are prevalent during early adulthood that can lead to cancer later in life. Emerging adults (EAs) aged 18-26 residing in rural areas of the United States engage in many cancer risk behaviors, especially sedentary lifestyles, poor eating patterns, nicotine product use, excess alcohol intake, infrequent sun protection, and inadequate uptake of the HPV vaccine. This application responds to RFA-CA-20-051, "Social and Behavioral Intervention Research to Address Modifiable Risk Factors for Cancer in Rural Populations." The goal is to improve cancer risk behavioral factors among diverse EAs aged 18-26 living in rural counties in the Four Corners states, a unique, underserved region, using a social media campaign designed with community advisors. EAs, including in rural communities, are heavy consumers of online content, especially over social media, and social media provide responsive, engaging, and low-cost platforms for distributing cancer prevention information with high dissemination potential. But, social media also circulate inaccurate, misleading, and harmful information. The specific aims of this research are to: 1) Develop a social media intervention for diverse EAs in rural communities via a community-engaged process that combines expert advice, user-generated content, and online instruction to communicate about behavioral cancer risks, cancer misinformation, counter marketing, digital and media literacy, and family communication; 2) evaluate the effect of a theory-based social media intervention on moderate to vigorous physical activity (MVPA), healthy eating patterns, nicotine product use, alcohol intake, sunburn prevalence, and HPV vaccination with the diverse population of EAs aged 18-26 in rural counties in AZ, CO, NM, and UT (Four Corners states) recruited from Qualtrics' survey panel and enrolled in a pragmatic randomized trial using a stepped-wedge design in which individual EAs will be randomized to 1 of 4 cohorts and receive the social media feed for varying durations in separate Facebook private groups; 3) test if improvements in EAs' cancer risk knowledge and beliefs, digital and media literacy skills, accurate cancer prevention information, and family communication mediate impact of the social media campaign; and 4) explore whether the impact of the social media campaign differs according to: a) level of EAs' engagement with campaign, b) cancer risk factors, and c) biological sex of the participants (as required by NIH). The research is innovative because it tests a theory-based, multi-risk factor approach to cancer prevention with diverse EAs in rural counties, an under-studied population, in a very popular new media. Social media may reach EAs more than interventions through other community channels (e.g., clinics, schools, and workplaces) and for lower cost in the geographically-dispersed, underserved rural communities in the Mountain West. The overall impact is extremely high because it will aid rural EAs in making informed decisions that reduce cancer risk factors and prevent cancer later in life and help EAs critically evaluate and resist misinformation and marketing that promote cancer risk behaviors.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 1000 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Intervention Model Description: Randomized stepped-wedge with four cohorts
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: #4Corners4Health: A Social Media Cancer Prevention Program for Rural Emerging Adults
Estimated Study Start Date : August 1, 2023
Estimated Primary Completion Date : November 30, 2026
Estimated Study Completion Date : February 28, 2027

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Vaccines

Arm Intervention/treatment
Experimental: 4 Corners Rural Cancer Prevention
Four separate Facebook groups, which provide information via posts within the private groups about cancer risk factors (e.g. reducing alcohol consumption, tobacco use cessation, increasing physical activity), behavioral skills to reduce them, benefits of, social support for, and ways to reduce social/financial costs of cancer prevention, and advice from health care providers to decrease barriers. Posts will seek to improve self- and response-efficacy and perceived risk, and link cancer prevention to personal goals.
Behavioral: 4 Corners Rural Health Cancer Prevention
Participants, aged 18-26, will join a private Facebook group to participate in the intervention. The group is not viewable to the public, including other Facebook users. Content that focuses on cancer prevention behaviors will be posted twice per day for up to 12 months. Each group will be hosted by a moderator who is responsible for managing the intervention goals and participants' engagement.




Primary Outcome Measures :
  1. Physical Activity [ Time Frame: Baseline ]
    Participants will self-report minutes per week of moderate to vigorous physical activity.

  2. Physical Activity [ Time Frame: 3 months ]
    Participants will self-report minutes per week of moderate to vigorous physical activity.

  3. Physical Activity [ Time Frame: 12 months ]
    Participants will self-report minutes per week of moderate to vigorous physical activity.

  4. Physical Activity [ Time Frame: 24 months ]
    Participants will self-report minutes per week of moderate to vigorous physical activity.

  5. Diet [ Time Frame: Baseline ]
    Participants will self-report intake per day of fruits, vegetables, whole grains/fiber, added sugars (from sugar-sweetened beverages), and red/processed meats.

  6. Diet [ Time Frame: 3 months ]
    Participants will self-report intake per day of fruits, vegetables, whole grains/fiber, added sugars (from sugar-sweetened beverages), and red/processed meats.

  7. Diet [ Time Frame: 12 months ]
    Participants will self-report intake per day of fruits, vegetables, whole grains/fiber, added sugars (from sugar-sweetened beverages), and red/processed meats.

  8. Diet [ Time Frame: 24 months ]
    Participants will self-report intake per day of fruits, vegetables, whole grains/fiber, added sugars (from sugar-sweetened beverages), and red/processed meats.

  9. Nicotine Product Use [ Time Frame: Baseline ]
    Participants will self-report tobacco/nicotine use in the past 30 days (every day, some days, not at all).

  10. Nicotine Product Use [ Time Frame: 3 months ]
    Participants will self-report tobacco/nicotine use in the past 30 days (every day, some days, not at all).

  11. Nicotine Product Use [ Time Frame: 12 months ]
    Participants will self-report tobacco/nicotine use in the past 30 days (every day, some days, not at all).

  12. Nicotine Product Use [ Time Frame: 24 months ]
    Participants will self-report tobacco/nicotine use in the past 30 days (every day, some days, not at all).

  13. Alcohol Intake [ Time Frame: Baseline ]
    Participants self-report consumption of number of alcoholic drinks in the past 30 days.

  14. Alcohol Intake [ Time Frame: 3 months ]
    Participants self-report consumption of number of alcoholic drinks in the past 30 days.

  15. Alcohol Intake [ Time Frame: 12 months ]
    Participants self-report consumption of number of alcoholic drinks in the past 30 days.

  16. Alcohol Intake [ Time Frame: 24 months ]
    Participants self-report consumption of number of alcoholic drinks in the past 30 days.

  17. Uv Exposure [ Time Frame: Baseline ]
    Participants will self-report number of sunburns.

  18. Uv Exposure [ Time Frame: 3 months ]
    Participants will self-report number of sunburns.

  19. Uv Exposure [ Time Frame: 12 months ]
    Participants will self-report number of sunburns.

  20. Uv Exposure [ Time Frame: 24 months ]
    Participants will self-report number of sunburns.

  21. HPV Vaccination [ Time Frame: Baseline ]
    Participants will self-report whether or not they have received one or more doses of the HPV vaccine.

  22. HPV Vaccination [ Time Frame: 3 months ]
    Participants will self-report whether or not they have received one or more doses of the HPV vaccine.

  23. HPV Vaccination [ Time Frame: 12 months ]
    Participants will self-report whether or not they have received one or more doses of the HPV vaccine.

  24. HPV Vaccination [ Time Frame: 24 months ]
    Participants will self-report whether or not they have received one or more doses of the HPV vaccine.


Secondary Outcome Measures :
  1. Physical Activity [ Time Frame: Baseline ]
    Participants will self-report number of minutes per week engaging in physical activity to determine if they meet the 150 minutes per week recommendation.

  2. Physical Activity [ Time Frame: 3 months ]
    Participants will self-report number of minutes per week engaging in physical activity to determine if they meet the 150 minutes per week recommendation.

  3. Physical Activity [ Time Frame: 12 months ]
    Participants will self-report number of minutes per week engaging in physical activity to determine if they meet the 150 minutes per week recommendation.

  4. Physical Activity [ Time Frame: 24 months ]
    Participants will self-report number of minutes per week engaging in physical activity to determine if they meet the 150 minutes per week recommendation.

  5. Diet [ Time Frame: Baseline ]
    Participants will self-report frequency of eating meals away from home/fast food.

  6. Diet [ Time Frame: 3 months ]
    Participants will self-report frequency of eating meals away from home/fast food.

  7. Diet [ Time Frame: 12 months ]
    Participants will self-report frequency of eating meals away from home/fast food.

  8. Diet [ Time Frame: 24 months ]
    Participants will self-report frequency of eating meals away from home/fast food.

  9. Nicotine Product Use [ Time Frame: Baseline ]
    Participants will self-report tobacco/nicotine use in the past 7 days (every day, some days, not at all).

  10. Nicotine Product Use [ Time Frame: 3 months ]
    Participants will self-report tobacco/nicotine use in the past 7 days (every day, some days, not at all).

  11. Nicotine Product Use [ Time Frame: 12 months ]
    Participants will self-report tobacco/nicotine use in the past 7 days (every day, some days, not at all).

  12. Nicotine Product Use [ Time Frame: 24 months ]
    Participants will self-report tobacco/nicotine use in the past 7 days (every day, some days, not at all).

  13. Nicotine Product Use [ Time Frame: Baseline ]
    Participants will self-report readiness to quit using a 10 point rating scale (1=no thought of quitting; 10=taking action to quit).

  14. Nicotine Product Use [ Time Frame: 3 months ]
    Participants will self-report readiness to quit using a 10 point rating scale (1=no thought of quitting; 10=taking action to quit).

  15. Nicotine Product Use [ Time Frame: 12 months ]
    Participants will self-report readiness to quit using a 10 point rating scale (1=no thought of quitting; 10=taking action to quit).

  16. Nicotine Product Use [ Time Frame: 24 months ]
    Participants will self-report readiness to quit using a 10 point rating scale (1=no thought of quitting; 10=taking action to quit).

  17. Alcohol Intake [ Time Frame: Baseline ]
    Participants will self-report number of times binge drinking in the past 30 days.

  18. Alcohol Intake [ Time Frame: 3 months ]
    Participants will self-report number of times binge drinking in the past 30 days.

  19. Alcohol Intake [ Time Frame: 12 months ]
    Participants will self-report number of times binge drinking in the past 30 days.

  20. Alcohol Intake [ Time Frame: 24 months ]
    Participants will self-report number of times binge drinking in the past 30 days.

  21. UV Exposure [ Time Frame: Baseline ]
    Participants will self-report sun protection behaviors with percent of sun exposure hours using sun protection.

  22. UV Exposure [ Time Frame: 3 months ]
    Participants will self-report sun protection behaviors with percent of sun exposure hours using sun protection.

  23. UV Exposure [ Time Frame: 12 months ]
    Participants will self-report sun protection behaviors with percent of sun exposure hours using sun protection.

  24. UV Exposure [ Time Frame: 24 months ]
    Participants will self-report sun protection behaviors with percent of sun exposure hours using sun protection.

  25. HPV Vaccination [ Time Frame: Baseline ]
    Participants will self-report if they have completed the series of HPV vaccination by receiving 3 doses of the vaccine.

  26. HPV Vaccination [ Time Frame: 3 months ]
    Participants will self-report if they have completed the series of HPV vaccination by receiving 3 doses of the vaccine.

  27. HPV Vaccination [ Time Frame: 12 months ]
    Participants will self-report if they have completed the series of HPV vaccination by receiving 3 doses of the vaccine.

  28. HPV Vaccination [ Time Frame: 24 months ]
    Participants will self-report if they have completed the series of HPV vaccination by receiving 3 doses of the vaccine.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 26 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Aged 18-26 years old
  • Resides in a county coded as RUCC 4-9 in Arizona, Colorado, New Mexico, or Utah
  • Able to speak and read English
  • Has regular social media engagement
  • Accepts screening call from study staff
  • Consents to participate

Exclusion Criteria:

  • Participated in community engagement activities
  • Cannot speak and read English
  • Has low or no social media engagement
  • Does not accept a screening call from study staff
  • Does not consent to participate
  • Does not give permission for engagement data to be extracted from Facebook private group
  • If biologically female, currently pregnant

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05618158


Contacts
Layout table for location contacts
Contact: David Buller, PhD 3035654321 dbuller@kleinbuendel.com
Contact: Alishia Kinsey 303-565-4321 akinsey@kleinbuendel.com

Locations
Layout table for location information
United States, Arizona
University of Arizona
Tucson, Arizona, United States, 85719
United States, Colorado
University of Colorado Denver
Aurora, Colorado, United States, 80045-2570
Contact: Evelinn Borrayo, PhD    303-724-0884    Evelinn.Borrayo@cuanschutz.edu   
Principal Investigator: Evelinn Borrayo, PhD         
Colorado State University
Fort Collins, Colorado, United States, 80521-4593
Contact: Kimberly Henry, PhD    970-491-5109    kim.henry@colostate.edu   
Principal Investigator: Kimberly Henry, PhD         
United States, New Mexico
University of New Mexico
Albuquerque, New Mexico, United States, 87131-0001
Contact: Andrew Sussman, PhD    505-272-4077    ASussman@salud.unm.edu   
Principal Investigator: Andrew Sussman, PhD         
United States, Utah
University of Utah
Salt Lake City, Utah, United States, 84112-5550
Contact: Deanna Kapka, PhD    801-587-4565    deanna.kepka@hci.utah.edu   
Principal Investigator: Deanna Kepka, PhD         
Sponsors and Collaborators
Klein Buendel, Inc.
National Cancer Institute (NCI)
University of Arizona
University of Utah
Colorado State University
University of Colorado, Denver
University of New Mexico
Investigators
Layout table for investigator information
Principal Investigator: David Buller, PhD Klein Buendel, Inc.
Layout table for additonal information
Responsible Party: Klein Buendel, Inc.
ClinicalTrials.gov Identifier: NCT05618158    
Other Study ID Numbers: 0341
1R01CA268037-01A1 ( U.S. NIH Grant/Contract )
First Posted: November 16, 2022    Key Record Dates
Last Update Posted: July 11, 2023
Last Verified: July 2023

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Klein Buendel, Inc.:
social media
cancer prevention
nicotine use
physical activity
nutrition
sun protection
alcohol use
HPV vaccine
media literacy